{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:55:48Z","timestamp":1762325748657,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.parkreldis.2023.105907","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:19:50Z","timestamp":1698783590000},"page":"105907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Randomized controlled trial of KW-6356 monotherapy in patients with early untreated Parkinson's disease"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-8343","authenticated-orcid":false,"given":"Tetsuya","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Hiraiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hatsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Ikebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunori","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kanzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeda","family":"Tetsuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutoshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Orimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemoto","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Shimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Tatsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuta","family":"Toru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Uozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.parkreldis.2023.105907_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","year":"2017","journal-title":"Lancet Neurol."},{"issue":"s1","key":"10.1016\/j.parkreldis.2023.105907_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"10291","key":"10.1016\/j.parkreldis.2023.105907_bib3","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.parkreldis.2023.105907_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1212\/WNL.0000000000012868","article-title":"Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN guideline subcommittee","volume":"97","author":"Pringsheim","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105907_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2012.03866.x","article-title":"Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson's disease","volume":"20","author":"Ferreira","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2023.105907_bib6","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.25364","article-title":"I. Stalevo reduction in dyskinesia evaluation in Parkinson's disease, factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease","volume":"28","author":"Olanow","year":"2013","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105907_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1474-4422(09)70225-X","article-title":"A reassessment of risks and benefits of dopamine agonists in Parkinson's disease","volume":"8","author":"Antonini","year":"2009","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105907_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1474-4422(11)70073-4","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes","volume":"10","author":"Rascol","year":"2011","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105907_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/mds.26724","article-title":"Long-term effects of rasagiline and the natural history of treated Parkinson's disease","volume":"31","author":"Rascol","year":"2016","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105907_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ene.13803","article-title":"Non-motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life","volume":"26","author":"Huang","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105907_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40263-020-00754-0","article-title":"Non-dopaminergic treatments for motor control in Parkinson's disease: an update","volume":"34","author":"Gonzalez-Latapi","year":"2020","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105907_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2023.105907_bib13","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.parkreldis.2020.09.025","article-title":"How do adenosine A(2A) receptors regulate motor function?","volume":"80","author":"Mori","year":"2020","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"21","key":"10.1016\/j.parkreldis.2023.105907_bib14","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/WNL.0b013e31821ccce4","article-title":"Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease","volume":"76","author":"Ramlackhansingh","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105907_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017338","article-title":"Adenosine A2A receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients","volume":"6","author":"Mishina","year":"2011","journal-title":"PLoS One"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2023.105907_bib16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awh128","article-title":"Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias","volume":"127","author":"Calon","year":"2004","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105907_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/14737175.2021.1880896","article-title":"Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson's disease","volume":"21","author":"Jenner","year":"2021","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105907_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.parkreldis.2009.06.008","article-title":"Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial","volume":"16","author":"Fernandez","year":"2010","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"23","key":"10.1016\/j.parkreldis.2023.105907_bib19","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1212\/WNL.0000000000004003","article-title":"Early Parkinson Disease Study, Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease","volume":"88","author":"Stocchi","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105907_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/molpharm.122.000633","article-title":"In vitro pharmacological profile of KW-6356, a novel adenosine A2A receptor antagonist\/inverse agonist","volume":"103","author":"Ohno","year":"2023","journal-title":"Mol. Pharmacol."},{"issue":"suppl 1","key":"10.1016\/j.parkreldis.2023.105907_bib21","article-title":"Effect of KW-6356, a novel adenosine A2A receptor antagonist\/inverse agonist, on motor and non-motor symptoms in Parkinson's disease patients as an adjunct to levodopa therapy: results of Phase 2b study [abstract]","volume":"37","author":"Maeda","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105907_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175773","article-title":"Anti-parkinsonian activity of the adenosine A2A receptor antagonist\/inverse agonist KW-6356 as monotherapy in MPTP-treated common marmosets","volume":"950","author":"Ohno","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2023.105907_bib23","unstructured":"Pharmaceuticals and Medical Devices Act (Japan). Standards for the Implementation of Clinical Trials on Pharmaceutical Products Ministry of Health and Welfare Ordinance No. 28; 27 March, 1997)."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105907_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"15","key":"10.1016\/j.parkreldis.2023.105907_bib25","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105907_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.parkreldis.2023.105907_bib27","series-title":"Clinical Global impressions., ECDEU Assessment Manual for Psychopharmacology","first-page":"218","author":"Guy","year":"1976"},{"issue":"12","key":"10.1016\/j.parkreldis.2023.105907_bib28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105907_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2009.03.002","article-title":"Target site occupancy: emerging generalizations from clinical and preclinical studies","volume":"122","author":"Grimwood","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105907_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072366","article-title":"The pharmacological potential of adenosine A2A receptor antagonists for treating Parkinson's disease","volume":"27","author":"Mori","year":"2022","journal-title":"Molecules"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:28:30Z","timestamp":1761179310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023009860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"alternative-id":["S1353802023009860"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105907","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled trial of KW-6356 monotherapy in patients with early untreated Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105907"}}